Cargando…

Asymmetric Dimethylarginine (ADMA) Levels Display a Morning Peak in Patients with Acute Myocardial Infarction

High Asymmetric Dimethylarginine (ADMA) levels are associated with increased platelet activity, elevated blood pressure, vasoconstriction and impaired vascular relaxation. We hypothesized that the myocardial infarction morning peak of occurrence is closely related to a morning peak of ADMA levels. W...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bergheanu, Sandrin C., van der Laarse, Arnoud, van der Bom, Johanna G., van der Hoeven, Bas L., le Cessie, Saskia, de Jong, Margreet G., Liem, Su-San, Schalij, Martin J., Jukema, J. Wouter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2011
Materias:	Other
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825079/ https://www.ncbi.nlm.nih.gov/pubmed/21734344 http://dx.doi.org/10.3233/DMA-2011-0781

Ejemplares similares

Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA)
por: Tain, You-Lin, et al.
Publicado: (2017)

Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality
por: Nijveldt, RJ, et al.
Publicado: (2003)

Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes
por: Tsikas, Dimitrios, et al.
Publicado: (2018)

Asymmetric Dimethylarginine (ADMA) and Endothelial Dysfunction: Implications for Atherogenesis
por: Landim, Maurício Batista Paes, et al.
Publicado: (2009)

Evaluation of Asymmetric Dimethylarginine (ADMA) Levels in Children with Growth Hormone Deficiency
por: Önder, Aşan, et al.
Publicado: (2014)

The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease
por: Sibal, Latika, et al.
Publicado: (2010)

Biological Functional Relevance of Asymmetric Dimethylarginine (ADMA) in Cardiovascular Disease
por: Franceschelli, Sara, et al.
Publicado: (2013)

Asymmetric Dimethylarginine in Chronic Obstructive Pulmonary Disease (ADMA in COPD)
por: Scott, Jeremy A., et al.
Publicado: (2014)

Asymmetric Dimethylarginin (ADMA) as a Marker of Endothelial Dysfunction in Primary Aldosteronism
por: Matrozova, Joanna, et al.
Publicado: (2016)

Asymmetric Dimethylarginine (ADMA) Levels Are Lower in Hemodialysis Patients Treated With Paricalcitol
por: Oliva-Damaso, Elena, et al.
Publicado: (2016)

Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA) Concentrations in Patients with Obesity and the Risk of Obstructive Sleep Apnea (OSA)
por: Arlouskaya, Yana, et al.
Publicado: (2019)

Asymmetric dimethylarginine (ADMA) is identified as a potential biomarker of insulin resistance in skeletal muscle
por: Lee, Woojung, et al.
Publicado: (2018)

Asymmetric (ADMA) and Symmetric (SDMA) Dimethylarginines in Chronic Kidney Disease: A Clinical Approach
por: Oliva-Damaso, Elena, et al.
Publicado: (2019)

Alterations of Asymmetric Dimethylarginine (ADMA)-Containing Protein Profiles Associated with Chronic Pancreatitis Pathogenesis
por: Tan, Chaochao, et al.
Publicado: (2021)

Elevated Levels of Asymmetric Dimethylarginine (ADMA) in the Pericardial Fluid of Cardiac Patients Correlate with Cardiac Hypertrophy
por: Nemeth, Zoltan, et al.
Publicado: (2015)

Asymmetric Dimethylarginine (ADMA) in Pediatric Renal Diseases: From Pathophysiological Phenomenon to Clinical Biomarker and Beyond
por: Hsu, Chien-Ning, et al.
Publicado: (2021)

The role of asymmetric dimethylarginine (ADMA) in COVID-19: association with respiratory failure and predictive role for outcome
por: Sozio, Emanuela, et al.
Publicado: (2023)

Asymmetric dimethylarginine (ADMA), nitric oxide metabolite, and estradiol levels in serum and peritoneal fluid in women with endometriosis
por: Kianpour, Maryam, et al.
Publicado: (2015)

The transporter and permeability interactions of asymmetric dimethylarginine (ADMA) and L-arginine with the human blood–brain barrier in vitro
por: Watson, Christopher P., et al.
Publicado: (2016)

Dimethylarginine Dimethylaminohydrolase 2 (DDAH 2) Gene Polymorphism, Asymmetric Dimethylarginine (ADMA) Concentrations, and Risk of Coronary Artery Disease: A Case-Control Study
por: Xuan, Chao, et al.
Publicado: (2016)

Symmetrical (SDMA) and asymmetrical dimethylarginine (ADMA) in sepsis: high plasma levels as combined risk markers for sepsis survival
por: Winkler, Martin Sebastian, et al.
Publicado: (2018)

Urinary Dimethylamine (DMA) and Its Precursor Asymmetric Dimethylarginine (ADMA) in Clinical Medicine, in the Context of Nitric Oxide (NO) and Beyond
por: Tsikas, Dimitrios
Publicado: (2020)

Metabolite asymmetric dimethylarginine (ADMA) functions as a destabilization enhancer of SOX9 mediated by DDAH1 in osteoarthritis
por: Wu, Yizheng, et al.
Publicado: (2023)

Author Correction: The role of asymmetric dimethylarginine (ADMA) in COVID-19: association with respiratory failure and predictive role for outcome
por: Sozio, Emanuela, et al.
Publicado: (2023)

Effect of Lowering Asymmetric Dimethylarginine (ADMA) on Vascular Pathology in Atherosclerotic ApoE-Deficient Mice with Reduced Renal Mass
por: Jacobi, Johannes, et al.
Publicado: (2014)

Positive correlation of airway resistance and serum asymmetric dimethylarginine (ADMA) in bronchial asthma patients lacking evidence for systemic inflammation
por: Tajti, Gabor, et al.
Publicado: (2018)

Urinary excretion of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine is positively related to nitric oxide level in tissues of normotensive and hypertensive rats
por: Szlęzak, Dominika, et al.
Publicado: (2023)

The renal transport protein OATP4C1 mediates uptake of the uremic toxin asymmetric dimethylarginine (ADMA) and efflux of cardioprotective L-homoarginine
por: Taghikhani, Emir, et al.
Publicado: (2019)

Asymmetric dimethylarginine (ADMA) accelerates renal cell fibrosis under high glucose condition through NOX4/ROS/ERK signaling pathway
por: Jayachandran, Isaivani, et al.
Publicado: (2020)

Plasma LDL-Cholesterol Level at Admission is Independently Associated with Infarct Size in Patients with ST-Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention
por: Bodde, Mathijs C., et al.
Publicado: (2019)

Exogenous Asymmetric Dimethylarginine (ADMA) in Pathogenesis of Ischemia-Reperfusion-Induced Gastric Lesions: Interaction with Protective Nitric Oxide (NO) and Calcitonin Gene-Related Peptide (CGRP)
por: Magierowski, Marcin, et al.
Publicado: (2014)

Asymmetric Dimethylarginine in COPD Exacerbation
por: Ozkarafakili, Mufide Arzu, et al.
Publicado: (2022)

Vectorial transport of the arginine derivatives asymmetric dimethylarginine (ADMA) and l-homoarginine by OATP4C1 and P-glycoprotein studied in double-transfected MDCK cells
por: Taghikhani, Emir, et al.
Publicado: (2020)

Modulation of calcification of vascular smooth muscle cells in culture by calcium antagonists, statins, and their combination
por: Trion, Astrid, et al.
Publicado: (2007)

Association between estimated glomerular filtration rate (eGFR) and asymmetric dimethylarginine (ADMA) concentrations among the elderly in a rural community: a cross-sectional study
por: Choi, Hye Rin, et al.
Publicado: (2019)

Asymmetric and Symmetric Dimethylarginine in Adolescents with Hyperuricemia
por: Tenderenda-Banasiuk, Edyta, et al.
Publicado: (2013)

Renal asymmetric dimethylarginine inhibits fibrosis
por: Wu, Ming, et al.
Publicado: (2020)

Growth Differentiation Factor-15 Levels at Admission Provide Incremental Prognostic Information on All-Cause Long-term Mortality in ST-Segment Elevation Myocardial Infarction Patients Treated with Primary Percutaneous Coronary Intervention
por: Bodde, Mathijs C., et al.
Publicado: (2019)

Cardiac resynchronization therapy; the importance of evaluating cardiac metabolism
por: van der Wall, E. E., et al.
Publicado: (2010)

Characterization of carotid plaques with a new CT technique
por: van der Laarse, Arnoud, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_6n3q7o20kq2rj5b1go9o2ept8h